Celldex Therapeutics acquires two biotechnology companies as Medarex takes a 60 percent stake in the company.
|
The hustle is on to get IPOs priced before the Independence Day holiday-shortened week.
|
Don’t look now, but the IPO market is coming to life as healthcare companies control the calendar.
|